Sign Up to like & get
recommendations!
0
Published in 2024 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-024-06806-7
Abstract: There is an unmet need for compounds to detect fibrillar forms of alpha-synuclein (αSyn) and 4-repeat tau, which are critical in many neurodegenerative diseases. Here, we aim to develop an efficient surface plasmon resonance (SPR)-based…
read more here.
Keywords:
tau;
syn fibrils;
amyloid beta;
binding sites ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Nature Communications"
DOI: 10.1038/s41467-021-22108-0
Abstract: The molecular architecture of α-Synuclein (α-Syn) inclusions, pathognomonic of various neurodegenerative disorders, remains unclear. α-Syn inclusions were long thought to consist mainly of α-Syn fibrils, but recent reports pointed to intracellular membranes as the major…
read more here.
Keywords:
syn inclusions;
synuclein;
situ architecture;
inclusions situ ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Nature Communications"
DOI: 10.1038/s41467-024-46538-8
Abstract: Parkinson’s disease (PD) is closely linked to α-synuclein (α-syn) misfolding and accumulation in Lewy bodies. The PDZ serine protease HTRA1 degrades fibrillar tau, which is associated with Alzheimer’s disease, and inactivating mutations to mitochondrial HTRA2…
read more here.
Keywords:
synuclein amyloid;
disaggregates synuclein;
syn fibrils;
htra1 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Science"
DOI: 10.1126/science.adp3645
Abstract: Neuronal accumulation and spread of pathological α-synuclein (α-syn) fibrils are key events in Parkinson's disease (PD) pathophysiology. However, the neuronal mechanisms underlying the uptake of α-syn fibrils remain unclear. In this work, we identified FAM171A2…
read more here.
Keywords:
neuronal fam171a2;
syn fibrils;
fam171a2 mediates;
parkinson disease ... See more keywords